comparemela.com

Latest Breaking News On - Health supported phase - Page 1 : comparemela.com

New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix s Bryostatin for Alzheimer s Disease

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for.

Daniel alkonRobert weinsteinJarin hongpaisanGeorge perryNational institutes of healthDrug administrationSynaptogenix incSemmes distinguished universityExchange commissionUniversity of texasKimmel medical college of thomas jefferson universityKimmel medical collegeThomas jefferson universityChief science officerScientific advisory boardSemmes distinguished university chair

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1 s Improved Cognition Over Baseline in Advanced Alzheimer s Disease Patients

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for.

Robert weinsteinExchange commissionDrug administrationPrnewswire synaptogenix incSynaptogenix incAdvanced alzheimerAbout synaptogenixHealth supported phaseOrphan drug designationMedia contact

vimarsana © 2020. All Rights Reserved.